Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1

Journal of Cellular Physiology

Volumn 183, Issue 3, 2000, Pages 399-410

  Pulverer, Bernd ^a,c   Sommer, Anette ^b,d   McArthur, Grant A ^a,e   Eisenman, Robert N ^a   Lüscher, Bernhard ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Nature   (United Kingdom)

^d BAYER PHARMA AG   (Germany)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INSULIN; ISOBUTYLMETHYLXANTHINE; MYC PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; MOUSE; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; 3T3 CELLS; ADIPOCYTES; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; COS CELLS; DEXAMETHASONE; DNA-BINDING PROTEINS; HUMANS; INSULIN; MICE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0034011222     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200006)183:3<399::AID-JCP13>3.0.CO;2-7     Document Type: Article

References (58)

1. Alland L, Muhle R, Hou Jr. H, Potes J, Chin L, Schrieber-Agus N, DePinho RA. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
2. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
3. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H. 1993a. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
4. Amati B, Littlewood TD, Evan GI, Land H. 1993b. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12:5083-5087.
5. Ayer DE, Eisenman RN. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7:2110-2119.
6. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
7. Ayer DE, Lawrence QA, Eisenman RN. 1995. Mad:Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of the yeast represser Sin3. Cell 80:767-776.
8. Bahram F, Wu S, Öberg F, Lüscher B, Larsson L-G. 1999. Post-translational regulation of Myc function in response to phorbol ester/interferon-γ-induced differentiation of v-Myc-transformed U-937 monoblasts. Blood 93:3900-3912.
9. Blackwood EM, Eisenman RN. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
10. Bousset K, Oelgeschläger M, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Lüscher-Firzlaff JM, Lüscher B. 1994. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell Mol Biol Res 40:501-511.
11. Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552.
12. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587-596.
13. Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD. 1995. Effects of the Myc oncogene antagonist. Mad, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nat Med 1:638-643.
14. Cornelius P, MacDougald OA, Lane MD. 1994. Regulation of adipocyte development. Annu Rev Nutr 14:99-129.
15. Cultraro CM, Bino T, Segal S. 1997. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol Cell Biol 17:2353-2359.
16. Facchini LM, Penn LZ. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 12:633-651.
17. Fajas L, Fruchart JC, Auwerx J. 1998. Transcriptional control of adipogenesis. Curr Opin Cell Biol 10:165-173.
18. Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN. 1998. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 17: 774-785.
19. Freytag SO. 1988. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol 8:1614-1624.
20. Freytag SO, Geddes TJ. 1992. Reciprocal regulation of adipogenesis by Myc and C/EBPa. Science 256:379-381.
21. Friedman AD, Landschulz WH. McKnight SL. 1989. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev 3:1314-1322.
22. Hann SR, Eisenman RN. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 4:2486-2497.
23. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347.
24. Heinzel T, Lavinsky RM, Mullen T-M, Söderström M, Laherty CD, Torchia J, Yang W-M, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
25. Henriksson M, Lüscher B. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
26. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681.
27. Hurlin PJ, Quéva C, Koskinen PJ, Steingrímsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN. 1995a. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14:5646-5659.
28. Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM. 1995b. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487-2501.
29. Hurlin PJ, Quéva C, Eisenman RN. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11:44-58.
30. Hwang CS, Loftus TM, Mandrup S, Lane MD. 1997. Adipocyte differentiation and leptin expression. Annu Rev Cell Dev Biol 13:231-259.
31. Koskinen PJ, Ayer DE, Eisenman RN. 1995. Mad repression of Myc-Ras cotransformation is mediated by multiple protein-protein interactions. Cell Growth Differ 6:623-629.
32. Laherty CD, Yang W-M, Sun J-M. Davie JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89:349-356.
33. Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci USA 91:5503-5507.
34. Larsson L-G, Pettersson M, Öberg F, Nilsson K, Lüscher B. 1994. Expression of mad, mxi1, max and c-myc during differentiation of hematopoetic cells: opposite regulation of mad and c-myc. Oncogene 9:1247-1252.
35. Larsson L-G, Bahram F, Burkhardt H, Lüscher B. 1997. Analysis of the DNA-binding activities of Myc-Max-Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene 15:737-748.
36. Lüscher B, Larsson L-G. 1999. The basic region/helix-loop-helix/ leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 18:2955-2966.
37. Lyle RE, Richon VM, McGehee RE. 1998. TNFalpha disrupts mitotic clonal expansion and regulation of retinoblastoma proteins p130 and p107 during 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 247:373-378.
38. MacDougald OA, Lane MD. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345-373.
39. McArthur GA, Laherty CD, Quéva C, Hurlin PJ, Loo L, James L, Grandori C, Gallant P, Shiio Y, Hokanson WC, Bush AC, Cheng PF, Lawrence QA, Pulverer B, Koskinen PJ, Foley KP, Ayer DE, Eisenman RN. 1998. The Mad protein family links transcriptional repression to cell differentiation. CSH Symp Quant Biol LXIII:423-433.
40. Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Lo Nigro C, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R. 1997. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional represser. EMBO J 16:2892-2906.
41. Piechaczyk M, Blanchard JM, Marty L, Dani C, Panabieres F, El Sabouty S, Fort P, Jeanteur P. 1984. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res 12:6951-6963.
42. Quéva C, Hurlin PJ, Foley KP, Eisenman RN. 1998. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene 16:967-977.
43. Reichert M, Eick D. 1999. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene 18:459-466.
44. Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN, Ayer DE. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 16:2796-2801.
45. Schmidt W, Poll-Jordan G, Löffler G. 1990. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP. J Biol Chem 265:15489-15495.
46. Schreiber-Agus N, Chin L, Chen K, Torres R. Rao G, Guida P, Skoultchi AI, DePinho RA. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
47. Shugart EC, Umek RM. 1997. Dexamethasone signaling is required to establish the postmitotic state of adipocyte development. Cell Growth Differ 8:1091-1098.
48. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Lüscher B. 1997. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 7:357-365.
49. Sommer A, Bousset K, Kremmer E, Austen M, Lüscher B. 1998. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J Biol Chem 273:6632-6642.
50. Sommer A, Waha A, Tonn J, Sörensen N, Hurlin PJ, Eisenman RN, Lüscher B, Pietsch T. 1999. Analysis of the Max-binding protein Mnt in human medulloblastomas. Int J Cancer 82:810-816.
51. Stanton LW, Watt R, Marcu KB. 1983. Translocation breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature 303:401-406.
52. Student AK, Hsu RY, Lane MD. 1980. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255:4745-4750.
53. Thompson EB. 1998. The many roles of c-Myc in apoptosis. Annu Rev Physiol 60:575-600.
54. Timchenko N, Wilsom DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ. 1995. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol 15:1192-1202.
55. Västrik I, Kaipainen A, Penttilä T-L, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol 128:1197-1208.
56. Yeh WC, McKnight SL. 1995. Regulation of adipose maturation and energy homeostasis. Curr Opin Cell Biol 7:885-890.
57. Yeh WC, Bierer BE, McKnight SL. 1995. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci USA 92:11086-11090.
58. Zervos AS, Gyuris J, Brent R. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.